Mobile

A 1-week, multi-center, randomized, double-blind, double-dummy, active-controlled, parallel trial of lumiracoxib (400 mg od) in patients with acute flares of gout, using indomethacin (50 mg tid) as a ...

Mise à jour : Il y a 4 ans
Référence : EUCTR2005-000229-51

A 1-week, multi-center, randomized, double-blind, double-dummy, active-controlled, parallel trial of lumiracoxib (400 mg od) in patients with acute flares of gout, using indomethacin (50 mg tid) as a comparator

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

The primary objective of this study is to demonstrate that lumiracoxib 400 mg od is not inferior to indomethacin 50 mg tid in the treatment of acute gout with respect to the mean change from baseline over days 2 to 5 of pain intensity assessed in the study joint approximately 4 hours after the first daily dose of study medication on each day.

Critère d'inclusion

  • Osteoarthritis

Liens